Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:30:51.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding notice and Revision: v3.4.1 text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:30.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a government funding status notice and a revision update (v3.4.1). The previous revision (v3.4.0) was removed.
    Difference
    0.4%
    Check dated 2026-02-04T06:33:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Glossary display is now shown by default and page metadata labels were updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4; this is a minor UI/metadata update that does not affect study data or content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:33:07.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added, replacing Revision: v3.3.3; this is an administrative update to the page version and does not affect study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:22:15.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a Locations section listing trial sites in Alabama, Iowa, Kansas, Kentucky, Minnesota, Missouri, New Hampshire, North Carolina, and Utah. Removed the HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T10:13:03.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.